시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
의약품 여과 시장 보고서 : 제품, 방법, 용도, 운영 규모, 지역별(2024-2032년)
Pharmaceutical Filtration Market Report by Product, Technique, Application, Scale of Operation, and Region 2024-2032
상품코드 : 1560938
리서치사 : IMARC Group
발행일 : 2024년 09월
페이지 정보 : 영문 138 Pages
 라이선스 & 가격 (부가세 별도)
US $ 2,999 ￦ 4,189,000
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 3,999 ￦ 5,586,000
PDF & Excel (5 User License) help
PDF, Excel 보고서를 동일 사업장의 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,999 ￦ 6,983,000
PDF & Excel (Corporate License) help
PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 의약품 여과 시장 규모는 2023년에 136억 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 658억 달러에 달하며, 2024-2032년 18.2%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 바이오의약품에 대한 수요 증가, 엄격한 규제 기준, 지속적인 기술 발전, 의약품 안전에 대한 관심 증가가 시장 성장을 가속하고 있습니다.

의약품 여과 시장 분석 :

의약품 여과 시장 동향 :

제약 및 생명공학 산업에서 지출 증가

제약회사들은 연구개발, 특히 단백질 정제 및 세포배양과 같은 공정에서 첨단 여과 기술을 필요로 하는 생명공학에 많은 투자를 하고 있습니다. 예를 들어 Statista에 따르면 대형 제약사들은 보통 매출의 20%를 연구개발에 투자하고 있습니다. 제약회사 아스트라제네카(AstraZeneca)는 2023년 처방약 매출의 23% 이상을 R&D에 투자할 예정입니다. 또한 단클론 항체 및 재조합 단백질을 포함한 바이오의약품 증가로 인해 제품의 품질과 수율을 보장하기 위해 특수 여과 방법이 필요합니다. 이러한 요인들은 제약 여과 시장의 성장을 더욱 촉진하고 있습니다.

제네릭 의약품 수요 증가

제네릭 의약품에 대한 수요 증가는 의약품 여과 시장의 성장을 이끄는 두드러진 요인 중 하나입니다. 예를 들어 IMARC에 따르면 2023년 세계 제네릭 의약품 시장 규모는 3,671억 달러에 달했습니다. 향후 IMARC 그룹은 2032년까지 이 시장이 6,280억 달러에 달하고 2024-2032년 연평균 성장률(CAGR)이 5.96%를 나타낼 것으로 예상하고 있습니다. 제네릭 의약품은 세계 수요를 충족시키기 위해 대량으로 생산되므로 품질과 규제 준수를 보장하기 위해 효율적이고 확장 가능한 여과 공정이 필요합니다. 이러한 요인들은 제약 여과 산업의 예측에 더욱 긍정적인 영향을 미치고 있습니다.

만성질환의 유병률 증가

만성질환의 유병률 증가는 다양한 의약품에 대한 수요를 증가시킵니다. 암, 당뇨병, 천식, COPD, 관절염 등 만성질환을 치료하기 위해 새로운 의약품이 도입되고 있습니다. 예를 들어 2023년 12월 아스트라제네카 파마 인도는 HER2 양성 유방암 치료에 사용되는 트루스투주맙 델크스테칸(일명 엔헬투)을 출시했습니다. 신약 출시는 일반적으로 시장 수요를 충족시키기 위해 생산량 확대가 필요합니다. 이러한 생산량 증가는 제품 품질과 규제 준수를 보장하기 위한 여과 기술에 대한 수요 증가와 직결됩니다. 이러한 요인들이 제약 여과 시장 점유율을 더욱 높이고 있습니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 의약품 여과 시장

제6장 시장 내역 : 제품별

제7장 시장 내역 : 방법별

제8장 시장 내역 : 용도별

제9장 시장 내역 : 운영 규모별

제10장 시장 내역 : 지역별

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 가격 분석

제15장 경쟁 구도

KSA
영문 목차

영문목차

The global pharmaceutical filtration market size reached US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 65.8 Billion by 2032, exhibiting a growth rate (CAGR) of 18.2% during 2024-2032. The escalating demand for biopharmaceuticals, stringent regulatory standards, ongoing technological advancements, and growing focus on drug safety are driving the market growth.

Pharmaceutical Filtration Market Analysis:

Pharmaceutical Filtration Market Trends:

Rising Spending in Pharmaceutical and Biotechnological Industries

Pharmaceutical companies are investing heavily in research and development, particularly in biotechnology, which requires advanced filtration technologies for processes such as protein purification and cell culture. For instance, according to Statista, large pharmaceutical businesses typically dedicate 20% of their earnings to research and development. Also, AstraZeneca, a pharmaceutical company, spent more than 23% of its prescription drug earnings in 2023 on research and development. Moreover, the rise in biopharmaceuticals, including monoclonal antibodies and recombinant proteins, requires specialized filtration methods to ensure product quality and yield. These factors are further driving the pharmaceutical filtration market growth.

Increasing Demand for Generic Drugs

The increasing demand for generic drugs is one of the prominent factors driving the growth in the pharmaceutical filtration market. For instance, according to IMARC, the global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. Generic drugs are manufactured in large volumes to meet global demand, necessitating efficient and scalable filtration processes to ensure quality and regulatory compliance. These factors are further positively influencing the pharmaceutical filtration industry forecast.

Growing Prevalence of Chronic Diseases

The increased prevalence of chronic diseases increases the demand for a variety of medications. New medications are introduced to address chronic conditions, such as cancer, diabetes, asthma, COPD, and arthritis. For instance, in December 2023, AstraZeneca Pharma India launched Trastuzumab Deruxtecan, also known as Enhertu, which is used to treat HER2-positive breast cancer. Each new drug launch typically requires scaled-up production to meet the market demand. This increased manufacturing volume directly correlates with higher demand for filtration technologies to ensure product quality and regulatory compliance. These factors are further contributing to the pharmaceutical filtration market share.

Global Pharmaceutical Filtration Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical filtration market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technique, application, and scale of operation.

Breakup by Product:

Membrane filters currently hold the majority of the total market share

The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the product. This includes membrane filters (MCE membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and others), prefilters and depth media (glass fiber filters, and PTFE fiber filters), single-use systems, cartridges and capsules, filter holders, filtration accessories, and others. According to the report, membrane filters hold the majority of the total market share.

According to the pharmaceutical filtration market outlook, membrane filters are essential in pharmaceutical manufacturing for processes, such as sterile filtration, virus filtration, and protein purification. They are used in bioprocessing applications for cell culture clarification, concentration, and separation of biomolecules. Moreover, in research laboratories, these are used for sample preparation, microbiological analysis, and particle removal in various scientific experiments. For instance, in December 2023, TeraPore Technologies, a nanofiltration membranes company, launched IsoBlock VF product line and IsoBlock PF Syringe Prefilter Device for parvovirus elimination from biopharmaceuticals. The IsoBlock PF Syringe Prefilter Device is an adsorptive membrane-based prefilter that removes undesired high-molecular-weight species from the feed prior to size-based virus removal.

Breakup by Technique:

Currently, microfiltration exhibits a clear dominance in the market

A detailed breakup and analysis of the pharmaceutical filtration market based on the technique has also been provided in the report. This includes microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others. According to the report, microfiltration exhibits a clear dominance in the market.

As per the pharmaceutical filtration market outlook, microfiltration is commonly used for sterile filtration to remove microorganisms and particles from pharmaceutical solutions and suspensions. This process is critical in preparing sterile drug products, such as injectables, ophthalmic solutions, and parenteral nutrition solutions. Moreover, it is used for clarification and particle removal in pharmaceutical manufacturing processes.

Breakup by Application:

Final product processing currently accounts for the largest market share

The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the application. This includes final product processing (active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccines and antibody processing, formulation and filling solutions, and viral clearance), raw material filtration (media buffer, pre-filtration, and bioburden testing), cell separation, water purification, and air purification. According to the report, final product processing accounts for the largest market share.

The demand for pharmaceutical filtration in final product processing is critical to ensure the safety, efficacy, and quality of pharmaceutical products before they reach consumers. Moreover, sterile filtration is essential to remove microorganisms and particles from pharmaceutical solutions and suspensions, ensuring they meet stringent sterility requirements. Final drug products, such as injectables (e.g., vaccines, antibiotics), ophthalmic solutions, and other sterile formulations, undergo sterile filtration to eliminate microbiological contaminants.

Breakup by Scale of Operation:

Currently, manufacturing scale exhibits a clear dominance in the market

The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the scale of operation. This includes manufacturing scale, pilot scale, and research and development scale. According to the report, manufacturing scale exhibits a clear dominance in the market.

Pharmaceutical manufacturing operates on large scales to meet global demand for medications. This volume necessitates robust filtration processes to ensure consistent product quality and safety. Moreover, regulatory agencies impose strict guidelines on pharmaceutical manufacturers to ensure product safety, efficacy, and purity. Filtration processes are crucial for meeting these regulatory standards.

Breakup by Region:

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical filtration.

According to the pharmaceutical filtration market statistics, the region has a strong presence of biopharmaceutical companies engaged in the production of biologics, vaccines, and biosimilars. For instance, in April 2024, Bavarian Nordic A/S, a fully integrated vaccine company, launched Jynneos, the only FDA-approved mpox vaccine in the United States. This sector requires advanced filtration technologies for processes like sterile filtration, virus filtration, and ultrafiltration/diafiltration (UF/DF). Moreover, continued investments in research and development by pharmaceutical companies and academic institutions fuel innovation in filtration technologies, supporting the market growth.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical filtration market. Also, detailed profiles of all major companies have been provided. Some of the companies covered are:

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Pharmaceutical Filtration Market Recent Developments:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Pharmaceutical Filtration Market

6 Market Breakup by Product

7 Market Breakup by Technique

8 Market Breakup by Application

9 Market Breakup by Scale of Operation

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기